Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
NANO.PAthis companyNanobiotix S.A.	€28.50	-38.24×	-10.94×	31.19×	-80.15×	-121.1%	100.0%	-36.5%	-80.8%	28.4%	-74.3%	-3.7%	-1.13×	-3.53×	-1.04×	1.09×	0.0%	2	3.95	2	C
ABVX.PAAbivax S.A.	€77.70	-24.93×	18.39×	0×	-31.6×	-91.3%	0.0%	0.0%	0.0%	-73.8%	-48.0%	-1.9%	0.07×	1.94×	-8.79×	8.75×	0.0%	3	37.94	2	C
ALCLS.PACellectis S.A.	€1.05	-7.05×	6.52×	6.52×	-24.8×	-443.6%	72.5%	-55.3%	-92.7%	-92.7%	-19.9%	-8.9%	1.2×	-1.38×	-4.98×	1.62×	0.0%	2	-1.71	1	D+
ALALTME.PATME Pharma N.V.	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
ALVIO.PAValerio Therapeutics S.A.	€0.49	-4.35×	10.27×	8.28×	51.4×	-135.2%	67.1%	-21.4%	-190.4%	-236.0%	-5.5%	2.4%	3.67×	12.09×	-1.96×	0.76×	0.0%	6	5.8	2	C
IPH.PAInnate Pharma S.A.	€1.31	-2.91×	-6.59×	51.33×	-2.46×	-112.1%	100.0%	-2058.0%	-1764.5%	226.6%	-146.1%	-37.0%	-1.04×	0.1×	-18.38×	1.27×	0.0%	3	-22.95	2	C
Peer median	—	-5.7×	8.39×	7.4×	-13.63×	-123.7%	69.8%	-38.3%	-141.5%	-83.3%	-33.9%	-5.4%	0.63×	1.02×	-6.88×	1.45×	0.0%	3	2.05	2	—